Senzime AB (OSTO:SEZI) YoY EBITDA Growth : 46.98% (As of Mar. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Senzime AB YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Senzime AB's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 46.98%.

Senzime AB's EBITDA per Share for the three months ended in Mar. 2024 was kr-0.19.

Senzime AB YoY EBITDA Growth Historical Data

The historical data trend for Senzime AB's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Senzime AB YoY EBITDA Growth Chart

Senzime AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

0.86

-40.35

-78.05

-54.25

29.32

Senzime AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EBITDA Growth	Get a 7-Day Free Trial															-25.52	38.31	22.03	47.95	46.98

Senzime AB YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Senzime AB's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(-1.256	-	-1.777)	/	\| -1.777 \|
=	29.32 %

Senzime AB's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2024 )
=	(EBITDA per Share (Q: Mar. 2024 )	-	EBITDA per Share (Q: Mar. 2023 ))	/	\| EBITDA per Share (Q: Mar. 2023 )) \|
=	(-0.193	-	-0.364)	/	\| -0.364 \|
=	46.98 %

Senzime AB YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Senzime AB's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Senzime AB (OSTO:SEZI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Senzime AB (OSTO:SEZI) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

SNZZF:USA 6YC:Germany

Address

Ulls vag 41, Uppsala, SWE, 756 51

Website

https://www.senzime.com

Senzime AB, a medical technology company, develops, manufactures, and markets patient monitoring systems for monitoring patients. Its solutions are designed to ensure maximum patient benefit, reduce complications associated with surgery and anesthesia, and decrease healthcare costs. Its product includes TetraGraph and TetraSens, ExSpiron, TetraSens Pediatric, and TetraConnect. Its geographical segments include Sweden, the United States, Europe/Oceania, and Asia.

Senzime AB (OSTO:SEZI) Headlines

No Headlines